Tissue Engineering: Promises, Potential, and Many Challenges

Tissue engineering and cell therapy research has been taking place for some 25 years, but to date relatively few products have reached the market. Comprising bioengineered products, cell therapy and gene therapy, tissue engineering (TE) can be considered a healthcare industry sub-sector combining elements of the biotechnology, medical device and pharmaceutical sectors. This combination of areas has begun to emerge on a larger scale in recent years, as increasing numbers of large pharma and medical device companies have begun to provide funding for smaller biotech companies, thus betting that at least some of the developing products and therapies will see highly profitable clinical application. "Source":[ http://www.mediligence.com/MedMarkets/sample_issue/apr05/MdMkts-04-05.pdf].

---